Transgene Biotek Share Price
TRABI
Live Transgene Biotek Share Price Chart
Transgene Biotek Performance
Days Range
| Previous Close | ₹2.79 |
|---|---|
| Open | ₹2.8 |
| Volume | 51,195 |
| Day's Range | ₹2.75 - ₹3.08 |
|---|---|
| 52W Range | ₹1.83 - ₹4.69 |
| Market Cap | ₹21.14 Cr |
Transgene Biotek Fundamentals
| ROCE(TTM) | -2.32 |
|---|---|
| P/E Ratio (TTM) | -13.29 |
| P/B Ratio | 2.52 |
| Industry P/E | 64.95 |
| Debt to Equity | 2.05 |
| ROE | -19.73 |
| EPS (TTM) | N/A |
| Dividend Yield | N/A |
| Book Value | 1.11 |
| Face Value | 10 |
| ROCE(TTM) | -2.32 |
|---|---|
| P/E Ratio (TTM) | -13.29 |
| P/B Ratio | 2.52 |
| Industry P/E | 64.95 |
| Debt to Equity | 2.05 |
| ROE | -19.73 |
|---|---|
| EPS (TTM) | N/A |
| Dividend Yield | N/A |
| Book Value | 1.11 |
| Face Value | 10 |
Transgene Biotek Financials
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Net Sales | 0.05 | 0.05 | 0.05 | 0.06 |
| Expenses | 0.18 | 0.15 | 0.38 | 0.16 |
| Profit before tax | -0.39 | -0.37 | -0.46 | -0.39 |
| Operating Profit | -0.39 | -0.37 | -0.46 | -0.39 |
| Net Profit | -0.39 | -0.37 | -0.46 | -0.39 |
| EPS in Rs | -0.05 | -0.05 | -0.06 | -0.05 |
Transgene Biotek Shareholding Pattern
Promoters
23.64%
Retail And Others
76.36%
Foreign Institutional Investors
0.00%
Domestic Institutional Investors
0.00%
About Transgene Biotek
Transgene Biotek was incorporated as a private limited company in Mar.'90 and was converted into a public limited company in Nov.'90.
The company is engaged in the research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for the qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.
Transgene Biotek's products are exported to Africa, Russia, China, Malaysia and the Phillipines. The company chalked out a new project for setting up a manufacturing facility at a cost of Rs.30 crore at the Anrich Industrial Area,Bollaram. TBL is working of four new plants:Oral deliver of proteins and peptides:DNA vaccines:fusion proteins and bio therapeutics. The new project is being funded by way of preferential offer to Batterymarch Financial management USA and other financial institutions.
Parent Organisation
Indian Private
Managing Director
K Koteswara Rao
Founded
1990
NSE Symbol
Top Mutual Funds Invested in Transgene Biotek Share
Data is not available currently. Please check back later.
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | 8,875.0 -45.50 (-0.51%) | ₹1,28,327.81 | 6,696.5 - 9,050.0 |
| Max Healthcare Institute Ltd | 995.5 -13.10 (-1.30%) | ₹98,297.62 | 903.0 - 1,275.0 |
| Manipal Health Enterprises Ltd | 727.35 20.40 (2.89%) | ₹93,043.21 | 625.45 - 730.0 |
| Aster DM Quality Care Ltd | 820.0 -2.35 (-0.29%) | ₹71,743.00 | 519.1 - 891.3 |
| Fortis Healthcare Ltd | 913.05 -15.95 (-1.72%) | ₹70,588.59 | 766.8 - 1,104.3 |
| Global Health Ltd | 1,414.7 -7.90 (-0.56%) | ₹38,237.60 | 956.0 - 1,491.0 |
Popular Stocks
Transgene Biotek Ltd FAQs
Can I buy Transgene Biotek Ltd (Transgene Biotek Ltd) from Angel One?
Yes, You can buy Transgene Biotek Ltd (Transgene Biotek Ltd) shares by opening a Demat account with Angel One.
How do I buy Transgene Biotek Ltd (Transgene Biotek Ltd) from Angel One?
Transgene Biotek Ltd (Transgene Biotek Ltd) share can be bought through the following modes:
1. Direct investment: You can buy Transgene Biotek Ltd (Transgene Biotek Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Transgene Biotek Ltd (Transgene Biotek Ltd) shares.
1. Direct investment: You can buy Transgene Biotek Ltd (Transgene Biotek Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Transgene Biotek Ltd (Transgene Biotek Ltd) shares.
